YDES (YD Bio) ROCE %: -193.04% (As of Dec. 2025)


YDES YD Bio Ltd YDES
12 GF Score
Price $2.35
! 1 Warning Sign
View Full Analysis

What is YD Bio ROCE %?

YD Bio YDES -2.89% 12 ROCE % is -193.04% as of Dec. 2025. GuruFocus rates YDES with a GF Score™ of 12/100. The stock has 1 warning sign investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. YD Bio's annualized ROCE % for the quarter that ended in Dec. 2025 was -193.04%.


YD Bio  (NAS:YDES) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.


YD Bio ROCE % Related Terms


YD Bio ROCE % Historical Data

* Premium members only.

The historical data trend for YD Bio's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

YD Bio ROCE % Chart

YD Bio Annual Data
Trend Dec23 Dec24 Dec25
ROCE %
0.00 -21.00 -88.74

YD Bio Semi-Annual Data
Dec24 Jun25 Dec25
ROCE % 0.00 -0.03 -193.04
YDES
12GF Score
YD Bio Ltd YDES
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

YD Bio ROCE % Calculation

YD Bio's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=-8.313/( ( (6.864 - 0.263) + (13.779 - 1.644) )/ 2 )
=-8.313/( (6.601+12.135)/ 2 )
=-8.313/9.368
=-88.74 %

YD Bio's ROCE % of for the quarter that ended in Dec. 2025 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Dec. 2025 )  (Q: Jun. 2025 )(Q: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Dec. 2025 )  (Q: Jun. 2025 )(Q: Dec. 2025 )
=-16.624/( ( (5.841 - 0.753) + (13.779 - 1.644) )/ 2 )
=-16.624/( ( 5.088 + 12.135 )/ 2 )
=-16.624/8.6115
=-193.04 %

(1) Note: The EBIT data used here is two times the semi-annual (Dec. 2025) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of -193.04% mean?
YD Bio (YDES) has a ROCE % of -193.04% as of Dec. 2025.
Is YD Bio's ROCE % too high?
YD Bio's current ROCE % is -193.04%. Overall, YD Bio has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does YD Bio's ROCE % compare to NERV and CAMP?
YD Bio's ROCE % of -193.04% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Biotechnology company?
A good ROCE % depends on the Biotechnology industry context. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. YD Bio's current ROCE % is -193.04%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is YD Bio stock overvalued right now?
YD Bio (YDES) has a current ROCE % of -193.04%. The current ROCE % is -193.04%. YD Bio's overall GF Score™ is 12/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For YD Bio (YDES), the current ROCE % is -193.04% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

YD Bio Business Description

Address No. 3, Xingnan Street, 12th Floor, Nangang District, Taipei City, TWN, 115001
YD Bio Ltd is a biotechnology company focused on regulated diagnostics, life science clinical services and healthcare product commercialization. Its operations include DNA methylation-based oncology testing programs in the United States under an LDT framework with CLIA-certified and CAP-accredited laboratory partners. The Company also provides life science distribution and clinical trial supply chain services, including procurement, logistics coordination and compliance-focused support for clinical development programs. It maintains ocular health product commercialization operations in the United States and consumer healthcare distribution activities in Asia. The Company operates in the United States and Taiwan, with Taiwan generating maximum revenue.
12GF Score

Get the complete analysis for YDES

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.35
Price